- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/58 - Protease inhibitors from animalsProtease inhibitors from humans from leeches, e.g. hirudin, eglin
Patent holdings for IPC class A61K 38/58
Total number of patents in this class: 58
10-year publication summary
|
6
|
7
|
2
|
5
|
2
|
3
|
6
|
7
|
4
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Maia Pharmaceuticals, Inc. | 19 |
4 |
| Boehringer Ingelheim International GmbH | 4750 |
3 |
| Boehringer Ingelheim Pharma GmbH & Co. Kg | 636 |
3 |
| Chiesi Farmaceutici S.p.A. | 966 |
3 |
| Universite Catholique de Louvain | 290 |
3 |
| The University of British Columbia | 1473 |
3 |
| Case Western Reserve University | 1776 |
2 |
| The Heart Research Institute Ltd | 24 |
2 |
| Lunan Pharmaceutical Group Corporation | 42 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2849 |
2 |
| Virologik GmbH | 7 |
2 |
| Novartis AG | 11221 |
1 |
| Novartis Pharma AG | 85 |
1 |
| Abbott Cardiovascular Systems, Inc. | 1114 |
1 |
| The Trustees of the University of Pennsylvania | 4288 |
1 |
| Duke University | 3030 |
1 |
| Acceleron Pharma Inc. | 374 |
1 |
| Aronora, Inc. | 15 |
1 |
| Children's Medical Center Corporation | 1838 |
1 |
| CSL Behring GmbH | 343 |
1 |
| Other owners | 20 |